Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Real Estate Developers Eye Boston’s South End for Life Science Campus

  • Post author:Sam
  • Post published:November 13, 2017
  • Post category:BioPharma

The new space is located just a few miles from Kendall Square that has become the hub of the Boston biotech industry. Source: BioSpace

Continue ReadingReal Estate Developers Eye Boston’s South End for Life Science Campus

Bristol-Myers Who? Why a Marriage Between Pfizer and Biogen Makes More Sense

  • Post author:Sam
  • Post published:November 13, 2017
  • Post category:BioPharma

Investors love to speculate on M&A, and one of the hottest topics of speculation recently has been whether someone will buy BMS. Source: BioSpace

Continue ReadingBristol-Myers Who? Why a Marriage Between Pfizer and Biogen Makes More Sense

Embattled Mylan Chops Another 200 to 300 Jobs

  • Post author:Sam
  • Post published:November 13, 2017
  • Post category:BioPharma

Two days after Mylan CEO Heather Bresch said she sees a "strong finish" for the company through the rest of 2017, the company has reportedly let between 200 and 300…

Continue ReadingEmbattled Mylan Chops Another 200 to 300 Jobs

Bay Area's Avinger Axes Jobs, Q3 Sales Down 61%

  • Post author:Sam
  • Post published:November 13, 2017
  • Post category:BioPharma

Beleaguered Avinger, is slashing more jobs. Source: BioSpace

Continue ReadingBay Area's Avinger Axes Jobs, Q3 Sales Down 61%

Novartis Showcases 4 Potential Blockbusters in Its Late-Stage Pipeline

  • Post author:Sam
  • Post published:November 13, 2017
  • Post category:BioPharma

Novartis is not resting on the laurels of having the first-ever-approval for a CAR-T cancer drug, Kymriah. Source: BioSpace

Continue ReadingNovartis Showcases 4 Potential Blockbusters in Its Late-Stage Pipeline

Pfizer Creates COO Role for CEO Ian Read's Rumored Successor

  • Post author:Sam
  • Post published:November 13, 2017
  • Post category:BioPharma

Albert Bourla, 56, has been the Group President of Pfizer’s Innovative Health Business since the beginning of 2016. Source: BioSpace

Continue ReadingPfizer Creates COO Role for CEO Ian Read's Rumored Successor

FDA Flags Outsourcer for Cybersecurity and Labeling Issues

  • Post author:Sam
  • Post published:November 13, 2017
  • Post category:Drug Industry Daily

The FDA cited a drug outsourcing facility in Bethlehem, Penn., for numerous compliance problems including inadequate computer security and lax labeling practices. Source: Drug Industry Daily

Continue ReadingFDA Flags Outsourcer for Cybersecurity and Labeling Issues

FDA Warns Home Infusion Company

  • Post author:Sam
  • Post published:November 13, 2017
  • Post category:Drug Industry Daily

The FDA cited an Illinois provider of home infusion therapy for failing to meet sterile production standards, according to a warning letter from the agency. Source: Drug Industry Daily

Continue ReadingFDA Warns Home Infusion Company

EMA and EUnetHTA Publish Joint Work Plan

  • Post author:Sam
  • Post published:November 13, 2017
  • Post category:Drug Industry Daily

The European Medicines Agency and the European Network for Health Technology Assessment released a joint work plan to help medicine developers improve clinical research and become more efficient in generating…

Continue ReadingEMA and EUnetHTA Publish Joint Work Plan

PTAB Issues New Rule Governing Attorney-Client Privilege

  • Post author:Sam
  • Post published:November 13, 2017
  • Post category:Drug Industry Daily

The PTO’s Patent Trial and Appeal Board issued a final rule clarifying when attorney-client privilege is recognized during the inter partes review process — as well as which communications are…

Continue ReadingPTAB Issues New Rule Governing Attorney-Client Privilege
  • Go to the previous page
  • 1
  • …
  • 258
  • 259
  • 260
  • 261
  • 262
  • 263
  • 264
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.